BioCentury
ARTICLE | Company News

Zymeworks, Merck deal

September 10, 2012 7:00 AM UTC

Zymeworks said it will receive a milestone from Merck triggered by the achievement of a research milestone under a 2011 deal to develop bi-specific antibodies using Zymework's Azymetric technology. Zy...